| CXCL2 |
CXCL2, GRO2, GROB, MIP2A, SCYB2: Macrophage inflammatory protein 2-alpha precurs |
GPR109B |
GPR109B: Nicotinic acid receptor 2 |
0.285 |
Evidence |
|
| CXCL2 |
CXCL2, GRO2, GROB, MIP2A, SCYB2: Macrophage inflammatory protein 2-alpha precurs |
ADORA2B |
ADORA2B: Adenosine receptor A2b |
0.285 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
RYK |
RYK, JTK5A: Tyrosine-protein kinase RYK precursor |
0.285 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
RGS17 |
RGS17: Regulator of G-protein signaling 17 |
0.285 |
Evidence |
|
| ADRA2B |
ADRA2B, ADRA2L1, ADRA2RL1: Alpha-2B adrenergic receptor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.285 |
Evidence |
|
| OSM |
OSM: Oncostatin-M precursor |
IL27RA |
IPI00006774 |
0.285 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
P2RY13 |
P2RY13, GPR86, FKSG77, GPR94: P2Y purinoceptor 13 |
0.285 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
P2RY5 |
P2RY5: P2Y purinoceptor 5 |
0.285 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
CCR7 |
CCR7, CMKBR7, EBI1, EVI1: C-C chemokine receptor type 7 precursor |
0.285 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
GPR45 |
High-affinity lysophosphatidic acid receptor homolog |
0.285 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
CXCR3 |
CXCR3, GPR9: C-X-C chemokine receptor type 3 |
0.285 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
GPR109B |
GPR109B: Nicotinic acid receptor 2 |
0.285 |
Evidence |
|
| BMP2 |
BMP2, BMP2A: Bone morphogenetic protein 2 precursor |
BMPR2 |
|
0.285 |
Evidence |
O
|
| CCL3 |
CCL3, G0S19-1, MIP1A, SCYA3: Small-inducible cytokine A3 precursor |
OPN3 |
OPN3, ECPN: Opsin-3 |
0.285 |
Evidence |
|
| CCL3 |
CCL3, G0S19-1, MIP1A, SCYA3: Small-inducible cytokine A3 precursor |
CXCR3 |
CXCR3, GPR9: C-X-C chemokine receptor type 3 |
0.285 |
Evidence |
|
| CCL3 |
CCL3, G0S19-1, MIP1A, SCYA3: Small-inducible cytokine A3 precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.285 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
ADORA2B |
ADORA2B: Adenosine receptor A2b |
0.285 |
Evidence |
|
| PYY |
PYY: Peptide YY precursor |
NPY5R |
NPY5R, NPYR5: Neuropeptide Y receptor type 5 |
0.285 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
RGS1 |
RGS1, 1R20, BL34, IER1: Regulator of G-protein signaling 1 |
0.285 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
SHB |
SHB: SH2 domain-containing adapter protein B |
0.285 |
Evidence |
|
| INHBA |
INHBA: Inhibin beta A chain precursor |
BMPR2 |
|
0.285 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
GRB7 |
GRB7: Growth factor receptor-bound protein 7 |
0.285 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
FYN |
IPI00640091 |
0.285 |
Evidence |
|
| MAS1 |
MAS1, MAS: MAS proto-oncogene |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
0.285 |
Evidence |
|
| CXCL10 |
CXCL10, INP10, SCYB10: Small-inducible cytokine B10 precursor |
OR1E2 |
OR1E2, OR1E4: Olfactory receptor 1E2 |
0.285 |
Evidence |
|